Phamaniaga to invest RM2mil for Covid-19 vaccine plant

KUALA LUMPUR: Pharmaniaga Bhd, a frontrunner to secure the government's contract to repackage and distribute the Covid-19 vaccine, said it will not be making substantial investment for the bottling of the vaccine at its plant in Puchong.

The company's acting managing director Mohamed Iqbal Abdul Rahman said the investment for the fill and finish process for the vaccine would be around RM2mil. He added it is suitable to be bottled at its facility in Puchong as it is a sterile liquid injection plant.

"There has to be a sterile environment for the vaccine to be bottled. We already have it, and can bottle the Covid-19 vaccine immediately once the vaccine is ready.Our capacity is around 10 million doses per month on 10 doses vial.

"In my opinion, I expect the vaccine to be available either by the first or second quarter of next year as it is in clinical trial in some countries. Most of the potential vaccine developers said the vaccine would be ready by year-end, he added at a press briefing.
Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

Did you find this article insightful?


50% readers found this article insightful

Next In Business News

Bintai Kinden plans fresh private placement to fund property venture
SC expands grant scheme to promote sustainable devt fund raising
Lower demand for oil pipes and valves hurts Pantech 3Q earnings�
Semicon, glove stocks losing their grip
Sources: Ant’s Malaysian e-wallet venture with CIMB in talks to raise US$150mil
Tenaga: 10,768 commercial customers to benefit from 10% Permai discount
RAM expects corporate bonds issuance of up to RM110b
Celcom introduces Celcom Cloud Suite to accelerate digital adoption
CIMB Thai FY20 net profit dips on higher provisions
Ageson appoints BASB as main contractor in mixed development project

Stories You'll Enjoy